Viewing Study NCT02091960

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:03 AM
Ignite Modification Date: 2026-03-06 @ 2:11 AM
Study NCT ID: NCT02091960
Status: COMPLETED
Last Update Posted: 2025-04-04
First Post: 2014-03-18
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: A Study to Assess the Efficacy and Safety of Enzalutamide With Trastuzumab in Patients With Human Epidermal Growth Factor Receptor 2 Positive (HER2+), Androgen Receptor Positive (AR+) Metastatic or Locally Advanced Breast Cancer
Sponsor: Astellas Pharma Global Development, Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None HER2 Amplified View
None Advanced Breast Cancer View
None Human Epidermal Growth Factor Receptor 2 (HER2) View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Xtandi View
None Enzalutamide View
None Trastuzumab View
None Breast cancer View
None HER2 View
None Androgen receptor positive View